HSBC Holdings’s GSK GSK Stock Holding History

HSBC Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,000	Closed	-$400K	–	3094
2019 Q2	$400K	Buy	+8,000	New	+$401K	﹤0.01%	2173

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HSBC Holdings's GSK Position: Q2 2026 in Review

HSBC Holdings sold out of GSK (GSK) in Q2 2026, closing a stake of 7,301 shares — an estimated $400K sold.

HSBC Holdings first reported a position in GSK in Q2 2013 and held it in 50 quarters. The position peaked at $162M in Q1 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

HSBC Holdings reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
HSBC Holdings sold 7,301 GSK shares in Q2 2026, an estimated $400K.
HSBC Holdings first reported a position in GSK in Q2 2013 and held it in 50 quarters.
HSBC Holdings's GSK position peaked at $162M in Q1 2024.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.